Emori T, Itonaga M, Ashida R, Tamura T, et al. Impact of sarcopenia on prediction of progression-free survival and overall survival of patients with pancreatic ductal adenocarcinoma receiving first-line gemcitabine and nab-paclitaxel chemotherapy. Pancreatology 2021 Dec 31. pii: S1424-3903(21)00660.
PMID: 35033425